Established in 2006, MD Biosciences Neuro is an industry-leading provider of preclinical and translational services focused on the development of neurology and pain assets. From in vitro to in vivo assays, we develop predictive models and methodologies that support clinical application. Our GLP-compliant laboratories are fully-equipped with advanced technologies, so we can build customizable research programs for our pharmaceutical and biotech partners. With the clinic in mind, our translational porcine models, library of behavioral assessments, and in vivo electrophysiology techniques characterize diseases of the nervous system and enhance therapeutic potential.